United States

People: ImmunoGen Inc (IMGN.OQ)

IMGN.OQ on NASDAQ Stock Exchange Global Select Market

12:47pm EDT
Change (% chg)

$-0.07 (-1.07%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Johnston, David 

DR. David B. Johnston is Executive Vice President and Chief Financial Officer of the Company. He has served as our Executive Vice President and Chief Financial Officer since that date. Prior to joining ImmunoGen, Mr. Johnston served as Chief Financial Officer of AVEO Pharmaceuticals, Inc., a biotechnology company, from 2007 to 2013. Prior to that he spent nine years at Genzyme Corporation, a biotechnology company, in roles of increasing responsibility, including Vice President, Finance and Chief Financial Officer of Genzyme Biosurgery from 1999 to 2003, and as Senior Vice President, Finance, Corporate Planning and Analysis from 2003 to 2007. Mr. Johnston holds a Master of Business Administration from the University of Michigan.

Basic Compensation

Total Annual Compensation, USD 544,519
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 1,054,670
Fiscal Year Total, USD 1,599,190

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --